Abstract:Osteoarthritis (OA) is a degenerative joint disease and is the main cause of chronic pain and functional disability in adults. Articular cartilage is a hydrated soft tissue that is composed of normally quiescent chondrocytes at a low density, a dense network of collagen fibrils with a pore size of 60-200 nm, and aggrecan proteoglycans with high-density negative charge. Although certain drugs, nucleic acids, and proteins have the potential to slow the progression of OA and restore the joints, these treatments have not been clinically applied owing to the lack of an effective delivery system capable of breaking through the cartilage barrier. Recently, the development of nanotechnology for delivery systems renders new ideas and treatment methods viable in overcoming the limited penetration. In this review, we focus on current research on such applications of nanotechnology, including exosomes, protein-based cationic nanocarriers, cationic liposomes/solid lipid nanoparticles, amino acid-based nanocarriers, polyamide derivatives-based nanocarriers, manganese dioxide, and carbon nanotubes. Exosomes are the smallest known nanoscale extracellular vesicles, and they can quickly deliver nucleic acids or proteins to the required depth. Through electrostatic interactions, nanocarriers with appropriate balance in cationic property and particle size have a strong ability to penetrate cartilage. Although substantial preclinical evidence has been obtained, further optimization is necessary for clinical transformation. STATEMENT OF SIGNIFICANCE: The dense cartilage matrix with high-negative charge was associated with reduced therapeutic effect in osteoarthritis patients with deep pathological changes. However, a systematic review in nanodevices for deep cartilage penetration is still lacking. Current approaches to assure penetration of nanosystems into the depth of cartilage were reviewed, including nanoscale extracellular vesicles from different cell lines and nanocarriers with appropriate balance in cationic property and size particle. Moreover, nanodevices entering clinical trials and further optimization were also discussed, providing important guiding significance to future research.

Intra-articular Nanodrug Delivery Strategies for Treating Osteoarthritis.

Intra-Articular Drug Delivery for Osteoarthritis Treatment

Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy

[Research Progress of Nanomaterials for Intra-Articular Targeted Drug Delivery in Treatment of Osteoarthritis].

Nanoparticle-Based Drug Delivery System—A Target Strategy for Osteoarthritis Treatment

Targeted treatment for osteoarthritis: drugs and delivery system

Progress in Intra-Articular Drug Delivery Systems for Osteoarthritis.

Intra‐Articular Injection of Nanomaterials for the Treatment of Osteoarthritis: From Lubrication Function Restoration to Cell and Gene Therapy

Advanced nanoparticles in osteoarthritis treatment

Cartilage-targeted drug nanocarriers for osteoarthritis therapy

Chondrocyte Membrane–coated Nanoparticles Promote Drug Retention and Halt Cartilage Damage in Rat and Canine Osteoarthritis

Stimuli-Sensitive Nanotherapies for the Treatment of Osteoarthritis

Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage

An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application

Application of Intra-articular Delivery Administration in the Treatment of Osteoarthritis

Drug Delivery Systems for the Treatment of Knee Osteoarthritis: A Systematic Review of In Vivo Studies

Nanodevices for deep cartilage penetration

Nanocrystal-chitosan particles for intra-articular delivery of disease-modifying osteoarthritis drugs

Polymer particles for the intra-articular delivery of drugs to treat osteoarthritis

Micro- and Nano-Carrier Mediated Intra-Articular Drug Delivery Systems for the Treatment of Osteoarthritis